Ct03897881 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ct03897881 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ct03897881 Today - Breaking & Trending Today

mRNA-4157 Plus Pembrolizumab Improves DMFS in High-Risk Melanoma

The combination of mRNA-4157 and pembrolizumab reduced the risk of developing distant metastasis or death by approximately 65% compared with pembrolizumab alone as adjuvant therapy in patients with resected melanoma at high risk of recurrence, according to findings from the phase 2 KEYNOTE-942 trial. ....

Muhammad Adnan Khattak , Edith Cowan University In Joondalup , Moderna Inc , Clinical Research , One Clinical Research , Edith Cowan University , Asco Annual Meeting , Rna 4157 V940 , Ct03897881 , Phase 2 Keynote 942 Trial ,